{"id":"fsh-ibsa","safety":{"commonSideEffects":[{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Abdominal pain/discomfort"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL2108427","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FSH-IBSA binds to FSH receptors on granulosa cells in the ovary, promoting follicle growth and maturation during assisted reproductive technology cycles. This leads to increased estrogen production and development of multiple mature oocytes suitable for retrieval and fertilization.","oneSentence":"FSH-IBSA is a recombinant human follicle-stimulating hormone (FSH) that stimulates ovarian follicle development and estrogen production in women undergoing fertility treatment.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:13:29.534Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Ovulation induction in women with anovulation or oligo-ovulation undergoing assisted reproductive technology"},{"name":"Controlled ovarian hyperstimulation in in vitro fertilization (IVF) cycles"}]},"trialDetails":[{"nctId":"NCT06659692","phase":"PHASE1","title":"Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2024-10-10","conditions":"Ovarian Stimulation, Infertility","enrollment":28},{"nctId":"NCT06781957","phase":"PHASE1","title":"Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2024-09-15","conditions":"OVARIAN STIMULATION, Infertility","enrollment":29},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Stimulation in the Ovary, IVF Outcome","enrollment":252},{"nctId":"NCT05778331","phase":"","title":"The Difference Between POSEIDON Group 3 and Group 4 as Regards IVF","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-10","conditions":"Infertility, Female, IVF","enrollment":340},{"nctId":"NCT03876145","phase":"NA","title":"The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2016-11-12","conditions":"Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome","enrollment":120},{"nctId":"NCT04539613","phase":"","title":"Controlled Ovarian Hyperstimulation (COH) With Sequential HPFSH & HMG Versus Rec-F.S.H Alone in ICSI Cycle","status":"UNKNOWN","sponsor":"Alaa Fouli Gaber Ebrahim","startDate":"2020-09-01","conditions":"Ovarian Stimulation in ICSI","enrollment":100},{"nctId":"NCT03373149","phase":"PHASE2","title":"Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response","status":"UNKNOWN","sponsor":"Riyadh Fertility and Reproductive Health center","startDate":"2017-11-29","conditions":"Infertility, Female","enrollment":228},{"nctId":"NCT04268927","phase":"PHASE2","title":"Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-04-01","conditions":"Infertility","enrollment":106},{"nctId":"NCT01969201","phase":"PHASE4","title":"FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2014-01","conditions":"Infertility","enrollment":710},{"nctId":"NCT03177538","phase":"PHASE4","title":"Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2017-09-04","conditions":"Infertility, Female","enrollment":32},{"nctId":"NCT01785095","phase":"PHASE3","title":"Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2013-03","conditions":"Oocyte Donation","enrollment":41},{"nctId":"NCT02304536","phase":"PHASE3","title":"Comparison Between Laparoscopic Ovarian Diathermy and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2014-11","conditions":"Infertility","enrollment":210},{"nctId":"NCT02304107","phase":"PHASE3","title":"Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2013-05","conditions":"Infertility","enrollment":140},{"nctId":"NCT02739516","phase":"PHASE3","title":"Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility","status":"COMPLETED","sponsor":"Benha University","startDate":"2014-06","conditions":"Unexplained Infertility","enrollment":108},{"nctId":"NCT02673632","phase":"","title":"The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2016-02","conditions":"Infertility","enrollment":30},{"nctId":"NCT02640976","phase":"EARLY_PHASE1","title":"Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program","status":"COMPLETED","sponsor":"Cairo University","startDate":"2013-06","conditions":"Infertility","enrollment":216},{"nctId":"NCT00335725","phase":"PHASE3","title":"Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2003-03","conditions":"Infertility","enrollment":151},{"nctId":"NCT00378001","phase":"PHASE3","title":"Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2005-03","conditions":"Infertility","enrollment":152},{"nctId":"NCT00823004","phase":"PHASE1, PHASE2","title":"Antagonist/Letrozole in Poor Responders","status":"COMPLETED","sponsor":"Yazd Research & Clinical Center for Infertility","startDate":"2008-06","conditions":"Ovarian Stimulation","enrollment":120},{"nctId":"NCT01212263","phase":"NA","title":"Clomiphene Citrate (CC) Co-treatment With HP Urinary FSH vs HP Urinary FSH in CC-resistant PCOS","status":"COMPLETED","sponsor":"Mansoura Integrated Fertility Center","startDate":"2010-01","conditions":"Polycystic Ovary Syndrome","enrollment":174},{"nctId":"NCT01219153","phase":"PHASE2","title":"Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET","status":"COMPLETED","sponsor":"Cairo University","startDate":"2008-09","conditions":"Infertility","enrollment":136}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"FSH-IBSA","genericName":"FSH-IBSA","companyName":"IBSA Institut Biochimique SA","companyId":"ibsa-institut-biochimique-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FSH-IBSA is a recombinant human follicle-stimulating hormone (FSH) that stimulates ovarian follicle development and estrogen production in women undergoing fertility treatment. Used for Ovulation induction in women with anovulation or oligo-ovulation undergoing assisted reproductive technology, Controlled ovarian hyperstimulation in in vitro fertilization (IVF) cycles.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}